- Home
- DC vs ATLN Comparison
DC vs ATLN Comparison
Compare DC & ATLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DC
- ATLN
- Stock Information
- Founded
- DC 2017
- ATLN 2014
- Country
- DC United States
- ATLN United States
- Employees
- DC N/A
- ATLN N/A
- Industry
- DC Precious Metals
- ATLN
- Sector
- DC Basic Materials
- ATLN
- Exchange
- DC Nasdaq
- ATLN NYSE
- Market Cap
- DC 209.6M
- ATLN 186.7M
- IPO Year
- DC N/A
- ATLN 2021
- Fundamental
- Price
- DC $3.32
- ATLN $2.50
- Analyst Decision
- DC Buy
- ATLN
- Analyst Count
- DC 1
- ATLN 0
- Target Price
- DC $7.50
- ATLN N/A
- AVG Volume (30 Days)
- DC 454.9K
- ATLN 20.3K
- Earning Date
- DC 03-27-2025
- ATLN 01-01-0001
- Dividend Yield
- DC N/A
- ATLN N/A
- EPS Growth
- DC N/A
- ATLN N/A
- EPS
- DC N/A
- ATLN N/A
- Revenue
- DC N/A
- ATLN $429,260,149.00
- Revenue This Year
- DC N/A
- ATLN N/A
- Revenue Next Year
- DC N/A
- ATLN N/A
- P/E Ratio
- DC N/A
- ATLN N/A
- Revenue Growth
- DC N/A
- ATLN 5.50
- 52 Week Low
- DC $1.84
- ATLN $1.30
- 52 Week High
- DC $3.50
- ATLN $8.98
- Technical
- Relative Strength Index (RSI)
- DC 67.37
- ATLN N/A
- Support Level
- DC $3.00
- ATLN N/A
- Resistance Level
- DC $3.50
- ATLN N/A
- Average True Range (ATR)
- DC 0.20
- ATLN 0.00
- MACD
- DC 0.06
- ATLN 0.00
- Stochastic Oscillator
- DC 86.05
- ATLN 0.00
About DC Dakota Gold Corp.
Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine.
About ATLN ATLANTIC INTERNATIONAL CORP
Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.